seed
Stage
1
Investors
About
TECregen AG develops precision-engineered biologics that regenerate the thymus to restore immune function, targeting immune decline, cancer, and inflammatory diseases.
Explore TECregen AG's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.